Search Results - "ENGELSMAN, E"

Refine Results
  1. 1
  2. 2

    Modulation of the IL‐2 production defect in vitro in Graves’disease by EISENSTEIN, Z., ENGELSMAN, E., WEISS, M., KALECHMAN, Y., SREDNI, B.

    Published in Clinical and experimental immunology (28-06-2008)
    “…SUMMARY IL‐2 production by mitogen‐induced peripheral blood mononuclear cells was reported to be reduced in several autoimmune diseases, including…”
    Get full text
    Journal Article
  3. 3

    Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences by Nooij, M.A, de Haes, J.C.J.M, Beex, L.V.A.M, Wildiers, J, Klijn, J, Becquart, D, Jassem, J, Engelsman, E, Duchateau, L

    Published in European journal of cancer (1990) (01-03-2003)
    “…The optimal duration of cytostatic treatment for metastatic breast cancer is still a matter of debate. Possible gain in the duration of remission has to be…”
    Get full text
    Journal Article
  4. 4

    Dutch policy on the management of drug-related problems by Engelsman, E L

    Published in British journal of addiction (01-02-1989)
    “…It is argued that the drug abuse problem should not be primarily seen as a problem of police and justice. It is essentially a manner of health. The Dutch…”
    Get more information
    Journal Article
  5. 5

    Drug misuse and the Dutch by Engelsman, E L

    Published in BMJ (02-03-1991)
    Get full text
    Journal Article
  6. 6

    Modulation of the IL-2 production defect in vitro in Grave's disease by EISENSTEIN, Z, ENGELSMAN, E, WEISS, M, KALECHMAN, Y, SREDNI, B

    Published in Clinical and experimental immunology (01-05-1994)
    “…IL-2 production by mitogen-induced peripheral blood mononuclear cells was reported to be reduced in several autoimmune diseases, including Graves' disease…”
    Get full text
    Journal Article
  7. 7

    The role of I-131-MIBG in the diagnosis and therapy of carcinoids by Hoefnagel, C A, den Hartog Jager, F C, Taal, B G, Abeling, N G, Engelsman, E E

    Published in European Journal of Nuclear Medicine (01-07-1987)
    “…The successful use of 131I-MIBG for the diagnosis and treatment of pheochromocytoma and neuroblastoma has led to its application in patients with carcinoid,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study by Schaake-Koning, C, van der Linden, E H, Hart, G, Engelsman, E

    “…Between 1977 and 1980, 118 breast cancer patients with locally advanced disease, T3B-4, any N, M0 or T1-3, tumor positive axillary apex biopsy, were randomized…”
    Get more information
    Journal Article
  10. 10

    Production of and response to interleukin-2 in Graves' disease by EISENSTEIN, Z, ENGELSMAN, E, WEISS, M, KALECHMAN, Y, SREDNI, B

    Published in Journal of clinical immunology (01-09-1988)
    “…Interleukin-2 is a lymphokine which is believed to play a central role in the regulation of the immune response. The production of and response to…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Clinical and laboratory findings in women with bacterial vaginosis and trichomoniasis versus controls by van der Meijden, W I, Duivenvoorden, H J, Both-Patoir, H C, Hazen-Engelsman, M E, Drogendijk, A C

    “…We report comprehensively on the clinical and laboratory findings in 30 women with bacterial vaginosis (BV), 30 with vaginal trichomoniasis and 30 with normal…”
    Get more information
    Journal Article
  16. 16

    Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics by van der Plas, Willemijn Y., Engelsman, Anton F., Umakanthan, Marille, Mather, Amanda, Sidhu, Stan B., Delbridge, Leigh W., Pollock, Carol, Waugh, David, Sywak, Mark S., Kruijff, Schelto

    Published in Surgery (01-01-2019)
    “…Since 2004, end-stage renal disease related hyperparathyroidism patients are treated mainly with cinacalcet, which ceased to be subsidized through the…”
    Get full text
    Journal Article
  17. 17

    Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer by Bruning, P F, Bonfrèr, J G, Engelsman, E, Hamersma-vd Linden, E, de Jong-Bakker, M, Nooyen, W

    Published in Breast cancer research and treatment (01-01-1984)
    “…In a phase II clinical trial, 38 postmenopausal women with advanced breast cancer were treated with aminoglutethimide and replacement hydrocortisone. All women…”
    Get full text
    Journal Article
  18. 18

    Alcohol policies in The Netherlands a three-pronged attack by Engelsman, E L

    Published in World health forum (1990)
    “…The Dutch will not readily accept restrictions on their freedom to drink alcohol. The government therefore relies on a mass education campaign urging…”
    Get more information
    Magazine Article
  19. 19

    Placental-site trophoblastic tumor: diagnosis, treatment, and biological behavior by Heintz, A P, Schaberg, A, Engelsman, E, van Hall, E V

    “…The clinical history of a patient with a placental-site trophoblastic tumor is presented. The diagnostic and therapeutic value of dilatation and curettage, the…”
    Get more information
    Journal Article
  20. 20